, Tracking Stock Market Picks
Enter Symbol:
AMAG Pharmaceuticals Inc. (AMAG) [hlAlert]

up 157.07 %

AMAG Pharmaceuticals Inc. (AMAG) rated Buy by FTN Equity Capital

Posted on: Thursday,  Mar 12, 2009  8:25 AM ET by FTN Equity Capital

FTN Equity Capital rated Buy AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) on 03/12/2009, when the stock price was $25.67.
Since then, AMAG Pharmaceuticals Inc. has gained 157.07% as of 01/25/2016's recent price of $65.99.
If you would have followed this FTN Equity Capital 's recommendation on AMAG, you would have gained 157.07% of your investment in 2510 days.

Advanced Materials Group Inc. develops, manufactures and markets a wide variety of industrial products. The company's principal subsidiary, Advanced Materials, Inc., is the successor to a business that converts specialty materials including foams, foils, films and adhesive composites into components and finished products such as printer cartridge inserts and inking felts, disk drive gaskets, automobile air conditioning insulators, water and dust seals, surgical pads and applicators for the medical, electronics, automotive and consumer products markets.

Having access to accurate and timely information is essential for success in today's marketplace. At FTN Equity Capital Markets, our focus is on providing thorough and objective research to our clients, empowering them to make the well-informed and educated decisions that help enhance their investment process. Our highly experienced team of analytical experts research, examine, and evaluate businesses in several markets, including consumer, health care, business and technology services, and financial service sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -55.79 %
1 Month down  -53.78 %
3 Months down  -60.43 %
1 YTD down  -32.68 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy